H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 82 Citations 27,834 248 World Ranking 601 National Ranking 357
Medicine D-index 85 Citations 29,609 304 World Ranking 7605 National Ranking 4155

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Asthma
  • Disease

His scientific interests lie mostly in Asthma, Internal medicine, Immunology, Placebo and Anesthesia. His Asthma research incorporates themes from Physical therapy, Severity of illness and Randomized controlled trial. His research in the fields of Atopy overlaps with other disciplines such as Exhaled nitric oxide.

His biological study spans a wide range of topics, including Gastroenterology, Asthma Control Questionnaire and Surgery. His studies in Anesthesia integrate themes in fields like Bronchodilation, Lung function, Crossover study and Refractory. His Reslizumab study combines topics from a wide range of disciplines, such as Benralizumab and Dupilumab.

His most cited work include:

  • Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program (1383 citations)
  • Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program (702 citations)
  • Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials (620 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Asthma, Internal medicine, Immunology, Severe asthma and Airway. Mario Castro studies Bronchial thermoplasty which is a part of Asthma. His work on Dupilumab, Lung function and Corticosteroid as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.

His Immunology study integrates concerns from other disciplines, such as Bronchoalveolar lavage and Disease. Mario Castro combines subjects such as Pathology, Lung and Cardiology with his study of Airway. His Placebo study incorporates themes from Adverse effect, Randomized controlled trial, Asthma Control Questionnaire and Reslizumab.

He most often published in these fields:

  • Asthma (63.48%)
  • Internal medicine (42.40%)
  • Immunology (28.92%)

What were the highlights of his more recent work (between 2018-2021)?

  • Asthma (63.48%)
  • Internal medicine (42.40%)
  • Severe asthma (15.93%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Asthma, Internal medicine, Severe asthma, Dupilumab and Immunology. Mario Castro conducted interdisciplinary study in his works that combined Asthma and Exhaled nitric oxide. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Placebo.

His work carried out in the field of Placebo brings together such families of science as Post-hoc analysis, Reslizumab and Adverse effect. His work deals with themes such as Corticosteroid use and Asthma exacerbations, which intersect with Dupilumab. His work in the fields of Immunology, such as Inflammation, overlaps with other areas such as Sputum.

Between 2018 and 2021, his most popular works were:

  • COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids. (158 citations)
  • Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline (104 citations)
  • Role of Biologics in Asthma. (80 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Asthma
  • Disease

His primary areas of investigation include Asthma, Internal medicine, Intensive care medicine, Exacerbation and Severe asthma. He has researched Asthma in several fields, including Placebo, Clinical trial, Airway and Disease. The Placebo study combines topics in areas such as Reslizumab and Adverse effect, Intention-to-treat analysis.

As part of one scientific family, Mario Castro deals mainly with the area of Internal medicine, narrowing it down to issues related to the Gastroenterology, and often Benralizumab, Crossover study and Mild asthma. His studies deal with areas such as Physical medicine and rehabilitation, Protocol and Allergic inflammation as well as Exacerbation. His research in Severe asthma intersects with topics in Psychological intervention and Eosinophil.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

Wendy C. Moore;Deborah A. Meyers;Sally E. Wenzel;W. Gerald Teague.
american thoracic society international conference (2010)

2024 Citations

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

Mario Castro;James Zangrilli;Michael E Wechsler;Eric D Bateman.
The Lancet Respiratory Medicine (2015)

977 Citations

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

Wendy C. Moore;Eugene R. Bleecker;Douglas Curran-Everett;Serpil C. Erzurum.
The Journal of Allergy and Clinical Immunology (2007)

900 Citations

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations

Dara G. Torgerson;Dara G. Torgerson;Elizabeth J. Ampleford;Grace Y. Chiu;W. James Gauderman.
Nature Genetics (2011)

786 Citations

Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: A multicenter, randomized, double-blind, sham-controlled clinical trial

Mario Castro;Adalberto S. Rubin;Michel Laviolette;Jussara Fiterman.
American Journal of Respiratory and Critical Care Medicine (2010)

780 Citations

Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-Controlled Study

Mario Castro;Sameer Mathur;Frederick Hargreave;Louis-Philippe Boulet.
American Journal of Respiratory and Critical Care Medicine (2011)

742 Citations

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Sally Wenzel;Mario Castro;Jonathan Corren;Jorge Maspero.
The Lancet (2016)

740 Citations

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

Mario Castro;Jonathan Corren;Ian D. Pavord;Jorge Maspero.
The New England Journal of Medicine (2018)

669 Citations

Tiotropium bromide step-up therapy for adults with uncontrolled asthma

Stephen P. Peters;Susan J. Kunselman;Nikolina Icitovic;Wendy C. Moore.
The New England Journal of Medicine (2010)

639 Citations

Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.

Yvonne J. Huang;Craig E. Nelson;Eoin L. Brodie;Todd Z. DeSantis.
The Journal of Allergy and Clinical Immunology (2011)

601 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mario Castro

Sally E. Wenzel

Sally E. Wenzel

University of Pittsburgh

Publications: 116

Christopher E. Brightling

Christopher E. Brightling

University of Leicester

Publications: 112

Kian Fan Chung

Kian Fan Chung

National Institutes of Health

Publications: 108

Peter G. Gibson

Peter G. Gibson

University of Newcastle Australia

Publications: 108

Scott T. Weiss

Scott T. Weiss

Harvard University

Publications: 105

Eugene R. Bleecker

Eugene R. Bleecker

University of Arizona

Publications: 104

Stanley J. Szefler

Stanley J. Szefler

University of Colorado Denver

Publications: 95

Ian D. Pavord

Ian D. Pavord

University of Oxford

Publications: 93

William W. Busse

William W. Busse

University of Wisconsin–Madison

Publications: 86

Pascal Chanez

Pascal Chanez

Aix-Marseille University

Publications: 84

Parameswaran Nair

Parameswaran Nair

McMaster University

Publications: 75

Guy Brusselle

Guy Brusselle

Ghent University Hospital

Publications: 72

Giorgio Walter Canonica

Giorgio Walter Canonica

Humanitas University

Publications: 70

Esteban G. Burchard

Esteban G. Burchard

University of California, San Francisco

Publications: 68

Carlos A. Camargo

Carlos A. Camargo

Harvard University

Publications: 68

Elisabeth H. Bel

Elisabeth H. Bel

University of Amsterdam

Publications: 68

Something went wrong. Please try again later.